Search Results for: Latest Updated SAP C-THR82-2405 Latest Version: SAP Certified Associate - Implementation Consultant - SAP SuccessFactors Performance and Goals | C-THR82-2405 Test Simulator Online 🍼 Open website 「 www.pdfvce.com 」 and search for 【 C-THR82-2405 】 for free download 🕵Valid C-THR82-2405 Exam Notes

REVISTA Nº 36

The best ophthalmology, with the the utmost safety...

A multicentre, randomized, double masked, 4-parallel, controlled, 6-month phase II study to assess the safety and efficacy of a cyclosporine PAD ophthalmic dispersion (0.06% and 0.03% CsA). Administered once daily in combination with lubricant therapy and safety monitoring three months after treatment in patients with moderate to severe xerophthalmia.

  RESEARCHER: Dr. Jesús Merayo Lloves ACTIVO   A multicentre, randomized, double masked, 4-parallel, controlled, 6-month phase II study to assess the safety and efficacy of a cyclosporine PAD ophthalmic...

“Double-blind, placebo-controlled phase I / II study to assess the efficiency and safety of AVX012 ophthalmic solution in subjects with mild to moderate dry eye”

  RESEARCHER: Dr. Jesús Merayo Lloves RECLUTANDO   “Double-blind, placebo-controlled phase I / II study to assess the efficiency and safety of AVX012 ophthalmic solution in subjects with mild to...

A dose-Ranging, Muti-Centre, Randmised, Double-Mased, Sham-Controlled, Parallel-Group Study of the Efficacy and safety of Opt-302 in Combination wiht Ranibizumab Compared with Ranibizumab Alone, in Patients with Neovascular Age-Related Macular Degeneration ( Wet AMD)

  RESEARCHER: Prof. Luis Fernández-Vega Sanz RECLUTANDO   A dose-Ranging, Muti-Centre, Randmised, Double-Mased, Sham-Controlled, Parallel-Group Study of the Efficacy and safety of Opt-302 in Combination wiht Ranibizumab Compared with Ranibizumab...

Phase IV, randomized, double-blind, simulated control study for the efficacy, safety, and tolerability of Aflibercept intravitreal monotherapy compared to Aflibercept and Concomitant Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy. (ATLANTIC)

  RESEARCHER: Dr. Álvaro Fernández-Vega Sanz ACTIVO   Phase IV, randomized, double-blind, simulated control study for the efficacy, safety, and tolerability of Aflibercept intravitreal monotherapy compared to Aflibercept and Concomitant...

Macular edema secondary to occlusion of the central

  RESEARCHER: Dr. Álvaro Fernández-Vega Sanz RECLUTANDO     INDICATION: Macular edema secondary to occlusion of the central TREATMENT: Aflibercept PROMOTOR: Bayer AG

...
2024 © Instituto Oftalmológico Fernández-Vega · All rights reserved
Legal notice
Privacy policy
Déjanos tus datos
Nos pondremos en contacto contigo
Please enable JavaScript in your browser to complete this form.
Casillas de verificación
REQUEST APPOINTMENT
We will contact you
Please enable JavaScript in your browser to complete this form.
Casillas de verificación
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.